Varenicline tartrate
Varenicline Tartrate (CP 526555-18) is a partial agonist of the α4β2 nicotinic acetylcholine receptor, derived from benzazepine. It is a well-established pharmacological aid for smoking cessation. This compound is widely used in neuroscience and addiction research, supporting both in vitro binding studies and in vivo behavioral models of nicotine dependence.
Product Specifications
CAS Number
375815-87-5
Product Name Alternative
Chantix; CP-526,555-18
Field of Research
Neuroscience
Purity
>98%
Form
Powder
Solubility
Soluble in DMSO (up to 18 mg/ml) or in Water (up to 35 mg/ml) .
Smiles
O[C@@H] ([C@H] (O) C (O) =O) C (O) =O.C1C2CNCC1c1cc3nccnc3cc21
Molecular Formula
C13H13N3·C4H6O6
Molecular Weight
361.4
Storage Conditions
-20°C
Notes
For research use only.
Other Product Names
7,8,9,10-Tetrahydro-6H-6,10-methanoazepino[4,5-g]quinoxaline tartrate:7,8,9,10-Tetrahydro-6,10-methano-6H-pyrazino (2,3-h) (3) benzazepine tartrate
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Lentiviral mouse Rdh12 shRNA (UAS) - Lentiviral mouse Rdh12 shRNA (UAS, iRFP) plasmid
